Mielcarek M, Roecklein B A, Torok-Storb B
Program in Transplantation Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98104, USA.
Blood. 1996 Jan 15;87(2):574-80.
The ability of granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood mononuclear cells (G-PBMCs) to induce secretion of cytokines in primary long-term marrow cultures (LTC) or in the human marrow stromal cell line HS23 was compared with that of marrow mononuclear cells. Equal numbers of G-PBMCs or marrow mononuclear cells were added to stromal cultures, supernatants were harvested at day 4 and levels of interleukin-1 alpha (IL-1 alpha), IL-1 beta, IL-2, IL-6, G-CSF, and tumor necrosis factor alpha (TNF alpha) were determined. G-PBMCs induced 21.4-fold higher levels of IL-6 and 12.5-fold higher levels of G-CSF in LTC cocultures compared with marrow mononuclear cells and induced 20.6-fold more IL-6 and 6.3-fold more G-CSF when added to HS23 cells. Experiments using sorted populations of CD20+, CD3+, and CD14+ cells showed that CD14+ cells within G-PBMCs were responsible for triggering the production of IL-6 and G-CSF. The effect did not require cell-cell contact and was inhibited when neutralizing antibodies to IL-1 alpha and IL-1 beta were used in combination. In these experiments, the greater stimulating ability of G-PBMCs is most likely attributable to the greater number of CD14+ cells in G-PBMCs (26.1+% +/- 2.3%) compared with marrow (2.5% +/- 0.8%), because equal numbers of CD14+ cells sorted from marrow and G-PBMCs showed comparable ability to induce IL-6 and G-CSF when placed directly on stromal cells.
将粒细胞集落刺激因子(G-CSF)动员的外周血单个核细胞(G-PBMCs)与骨髓单个核细胞在原代长期骨髓培养物(LTC)或人骨髓基质细胞系HS23中诱导细胞因子分泌的能力进行了比较。将等量的G-PBMCs或骨髓单个核细胞加入到基质培养物中,在第4天收集上清液,并测定白细胞介素-1α(IL-1α)、IL-1β、IL-2、IL-6、G-CSF和肿瘤坏死因子α(TNFα)的水平。与骨髓单个核细胞相比,G-PBMCs在LTC共培养物中诱导的IL-6水平高21.4倍,G-CSF水平高12.5倍;当加入到HS23细胞中时,诱导的IL-6多20.6倍,G-CSF多6.3倍。使用分选的CD20 +、CD3 +和CD14 +细胞群体进行的实验表明,G-PBMCs中的CD14 +细胞负责触发IL-6和G-CSF的产生。该效应不需要细胞间接触,当联合使用抗IL-1α和IL-1β的中和抗体时受到抑制。在这些实验中,G-PBMCs更强的刺激能力最可能归因于其CD14 +细胞数量(26.1% ± 2.3%)比骨髓(2.5% ± 0.8%)更多,因为从骨髓和G-PBMCs中分选的等量CD14 +细胞直接置于基质细胞上时,诱导IL-6和G-CSF的能力相当。